Purchases and Sales Made in Q3 2022 in Mi Nk Therapeutics, Inc. (INKT)
This table provides information about the institutional ownership of Mi Nk Therapeutics, Inc. (INKT) during Q3 2022. The information is specifically focused on institutions that hold shares of MiNK Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 03, 2022
Q3 2022
|
First Republic Investment Management, Inc.
San Francisco, CA |
BUY
|
- |
81.5KNew |
$97K - $277K
|
81.5K
$59.5K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
49.1KNew |
$58.4K - $167K
|
49.1K
$35.8K
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
11.1KNew |
$13.2K - $37.8K
|
11.1K
$8.11K
|
|
Nov 09, 2022
Q3 2022
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
10.4KNew |
$12.4K - $35.4K
|
10.4K
$7.59K
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
3.37K+ 50.7% |
$4.01K - $11.4K
|
10K
$7.3K
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
468New |
$557 - $1.59K
|
468
$342
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
9+ 40.91% |
$10.7 - $30.6
|
31
$22.6
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-421- 90.93% |
$501 - $1.43K
|
42
$30.7
|